Disruptive Technologies in Pharma

20/01/2020 - 21/01/2020

The conference aims to bring together experts of emerging technologies to discover the opportunities with regards to Artificial intelligence, Machine Learning, Internet of Things, Digital therapeutics, eHealth and blockchain. The effect of these technologies on the industry will be discussed with the aim to highlight challenges related to the implementation of these new technologies and to discuss how to overcome them.

Industry case studies will reveal personal experiences and strategies to approaching digitalization, providing a benchmark for practice and improving understanding of forecasts until 2020.

Transformations require regulatory adjustments therefore, the conference will also feature insights into new regulatory guidelines and standards of practice, with special focus on the new class of drugs called digital therapeutics, to provide a complete picture of every aspect of the transformation process.

Network and learn from leading professionals such as Vice Presidents, Directors Managers and Heads of: Emerging/Disruptive Technologies, Artificial Intelligence, Machine Learning, Data Science/Analytics, Technology, External and Internal Innovation, Digital IoT and Bioinformatics


  • Karl Hess, Managing Director, OnDigitalHealth Consulting


  • Mark Campbell, Freelance Regulatory Expert, former NICE
  • Vladimir Anisimov, Principal Data Scientist, Amgen
  • Joseph Dalton, Global Lead Digital Health Solutions and Medical Outcomes, Novartis

For more information and to register, visit: www.disruptivetech-pharma.com/Phorum

Additional Contact Info:

T: +44 (0) 20 7827 6164

E: nhoward@smi-online.co.uk